Confident Investing Starts With TipRanks Premium

Get 55% Off
TipRanks
Go Ultimate55% OFF

Ian Clark Insider Profile

11 Followers

Ian Clark, Director at Guardant Health, holds 2.98K shares in Guardant Health (Ticker: GH), holds 14.49K shares in BioMarin Pharmaceutical (Ticker: BMRN), holds 21.73K shares in Kyverna Therapeutics, Inc. (Ticker: KYTX).

Ian Clark's Trading History

GHGuardant Health		Aug 05, 2026DirectorUninformative Buy551.00K$531.93K
BMRNBioMarin Pharmaceutical		Jun 04, 2026DirectorUninformative Buy―$847.81K
KYTXKyverna Therapeutics, Inc.		May 29, 2026DirectorUninformative Buy―$123.19K
OLMAOlema Pharmaceuticals		Dec 23, 2025DirectorUninformative Buy1.22M$0.00
GDRXGoodRx Holdings		Jul 09, 2025DirectorUninformative Buy81.76K$349.52K
AGIOAgios Pharma		May 24, 2022DirectorUninformative Buy33.44K$200.07K
KITEKite Pharma Inc		Oct 05, 2017―Uninformative Sell319.68K―
TVIAQTerraVia Holdings Inc		Jun 03, 2011―Informative Buy54.00K$45.00
DNDNQDendreon Corp		Aug 23, 2010―Informative Sell280.95K―
FTSVForty Seven		――――
TECXTectonic Therapeutic		―Director――
CRVSCorvus Pharmaceuticals		―Director――
See All Insider Trading from Today

You May Also Like

Meet our Smart Portfolio. See what top analysts say about your stocks.Get a breakdown of the different strategies based on detected insider trading activity.Find the best performing Analyst in each sector. Follow them so you never miss a recommendation.

Ian Clark insider profile FAQ

What is the percentage of profitable transactions made by Ian Clark?
The percentage of profitable transactions made by Ian Clark is 17%.
What is the average return per transaction made by Ian Clark?
The average return per transaction made by Ian Clark is -72.80%.
What stocks does Ian Clark hold?
Ian Clark holds: GH, BMRN, TVIAQ, AGIO, KITE, CRVS, TECX, FTSV, GDRX, OLMA, KYTX, DNDNQ stocks.
What was Ian Clark’s latest transaction?
Ian Clark’s latest transaction was an Uninformative Buy of $551.00K.
What was Ian Clark's most profitable transaction?
Ian Clark’s most profitable transaction was an Informative Sell of OLMA stock on December 23, 2025. The return on the trade was 74.70%.
What is Ian Clark's role in Guardant Health?
Ian Clark's role in Guardant Health is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.